GSK Expands Consumer Business With Acquisition Of OTC Cold Sore Products
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline further expands its rapidly growing consumer health care business by acquiring exclusive marketing rights to two cold sore treatments in a week, just months after announcing a third deal in the category
You may also be interested in...
Meda Lands In U.S. OTC Space With Alaven Buy
Meda Pharmaceuticals acquires a larger U.S. presence with an eye on OTC growth, including potential switch candidates
Meda Lands In U.S. OTC Space With Alaven Buy
Meda Pharmaceuticals acquires a larger U.S. presence with an eye on OTC growth, including potential switch candidates
Meda Lands In U.S. OTC Space With Alaven Buy
Meda Pharmaceuticals acquires a larger U.S. presence with an eye on OTC growth, including potential switch candidates